Abstract: A method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker are disclosed. Firstly, a specimen is obtained from a testee. Next, the specimen is tested for its MIP-3? expression level. Then, the MIP-3? expression level of the specimen is compared with that of a control. Finally, the malignancy of nasopharyngeal carcinoma is determined according to a relative MIP-3? expression level between the specimen and the control.

Abstract: The present invention discloses a bladder cancer biomarker and a test method using the same. The biomarker contains at least one of the mentioned 69 compounds, such as apolipoprotein A1 (APOA1), apolipoprotein A2 (APOA2), peroxiredoxin 2 (PRDX2), heparin cofactor 2 precursor (HCII), and serum amyloid A-4 protein (SAA4), which exist in the urine specimen of a testee. The expression intensity of the biomarker can facilitate diagnosis of bladder cancer and evaluation of aggressiveness and malignancy of bladder cancer. Thereby, the physician can arrange an optimized treatment to achieve the best therapeutic effect.

Abstract: A digital PLL frequency synthesizer characterized by fast-locking and low-jitters is presented. The PLL comprises a phase detector, a controllable oscillator, a loop filter having an automatically-adjusted loop gain, a feedback phase integration circuit, and a reference phase integration circuit. Fast-locking is achieved by dynamically adjusting forward-path gain and integral-path gain according to the output of the phase detector and the output of the integral-path during phase tracking. A skew-compensated counter circuit is proposed, which incorporates an asynchronous counter, a data register and a sample phase generator and features high-speed and low-power operation.

Abstract: A method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker are disclosed. Firstly, a specimen is obtained from a testee. Next, the specimen is tested for its MIP-3? expression level. Then, the MIP-3? expression level of the specimen is compared with that of a control. Finally, the malignancy of nasopharyngeal carcinoma is determined according to a relative MIP-3? expression level between the specimen and the control.

Abstract: A method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker are disclosed. Firstly, a specimen is obtained from a testee. Next, the specimen is tested for its MIP-3? expression level. Then, the MIP-3? expression level of the specimen is compared with that of a control. Finally, the malignancy of nasopharyngeal carcinoma is determined according to a relative MIP-3? expression level between the specimen and the control.

Abstract: The present invention discloses an oral cancer biomarker and an inspection method using the same. The biomarker is Mca-2 binding protein (Mac-2BP), which can be directly detected in the specimen of the body fluid of a testee, and which can realize a fast and effective clinical diagnosis of oral cancer.

Abstract: The present invention discloses an oral cancer biomarker and an inspection method using the same. The biomarker is Mca-2 binding protein (Mac-2BP), which can be directly detected in the specimen of the body fluid of a testee, and which can realize a fast and effective clinical diagnosis of oral cancer.

Abstract: A digital PLL frequency synthesizer characterized by fast-locking and low-jitters is presented. The PLL comprises a phase detector, a controllable oscillator, a loop filter having an automatically-adjusted loop gain, a feedback phase integration circuit, and a reference phase integration circuit. Fast-locking is achieved by dynamically adjusting forward-path gain and integral-path gain according to the output of the phase detector and the output of the integral-path during phase tracking. A skew-compensated counter circuit is proposed, which incorporates an asynchronous counter, a data register and a sample phase generator and features high-speed and low-power operation.

Abstract: A network device for processing data on a data network including a port interface, in communication with a plurality of ports, configured to receive a data packet from a data network, determine a filter index value for the data packet and to send a processed data packet to an egress port of the plurality of ports and a packet filtering module, in communication with the port interface, configured to filter the received data packet to obtain filter values and modify the received data packet to form the processed data packet based on the filter values. The packet filter module is configured to determine whether the data packet is within a predetermined socket range by performing a lookup of a filter index table using the filter index value concurrently with the filtering of the data packet to obtain the filter values.

Abstract: A network device for processing data on a data network includes a port interface, in communication with a plurality of ports, configured to receive a data packet from a data network and to send a processed data packet to an egress port of the plurality of ports and a packet evaluation and modification module, in communication with the port interface, configured to parse the received data packet, perform lookup searches based on parsed data packet values and modify the received data packet based on results of the lookup searches to form the processed data packet. The packet evaluation and modification module is configured to perform a table search using a slice of a generated key to obtain a chain result and then to perform another table search using another slice of the generated key and the chain result to produce at least a partial lookup table search result.

Abstract: A network device for processing data on a data network includes a port interface, in communication with a plurality of ports, configured to receive a data packet from a data network and assign an ingress interface number to the data packet and a packet evaluation module, in communication with the port interface, configured to parse the received data packet and modify the received data packet, if needed based on the ingress interface number. The port interface assigns the ingress interface number based on at least one of a port of the plurality of ports upon which the data packet was received and a virtual local area network through which the data packet was received.

Abstract: A network device for processing data on a data network including a port interface configured to receive a data packet from a data network and to send a processed data packet to an egress port of the plurality of ports, a memory management unit controlling a memory and a search engine configured to perform searches of lookup tables and to return search results to assist in modifying the received data packet to produce the processed data packet. The port interface is configured to assign a virtual forwarding instance (VFI) identifier for the data packet when received and configured to perform appropriate encapsulation of the processed data packet based on the VFI identifier.

Abstract: Process for the preparation of an efficient industrial .alpha., .omega.-dilithio poly(conjugated diene) diinitiator having a peak molecular weight in the range of from 1000 to 3000, comprising the reaction of mono-organolithium initiator with diisopropenyl benzene in an apolar hydrocarbon solvent, optionally in the presence of a tertiary amine, followed by addition to the reaction mixture of a small amount of conjugated diene monomer and at least 15 vol % of an aromatic ether activator at a temperature in the range of from 0.degree. to 30.degree. C.; the use of said .alpha., .omega.-dithio initiator for the manufacture of symmetrical block copolymers by anionic polymerization, from monovinylaromatic, conjugated diene and/or polar vinyl compound monomers; and block copolymers so obtained having a combination of a narrow molecular weight distribution (Mw/Mn.ltoreq.1.20) and relatively low vinyl content (.ltoreq.18%).

Abstract: The present invention provides a sulfated polysaccharide (D-HG), a pharmaceutically acceptable salt thereof, a process for preparing the same and a medicament containing the same as the effective component for DIC (disseminated intravascular coagulation) and thrombosis, the sulfated polysaccharide (D-HG) being prepared by depolymerization of FGAG (a sulfated polysaccharide extracted from a body wall of a sea cucumber with such activities as those of heparin) or a salt thereof and having the following physicochemical properties:[1] Molecular weight:3,000 to 42,000 (as measured by high performance GPC)[2] Characteristic:white, amorphous, highly hygroscopic powder[3] Solubility:soluble in water but insoluble in ethanol, acetone and like organic solvents[4] Specific rotation:[.alpha.].sub.D.sup.20 =-55 to -73.degree.